BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36435719)

  • 1. How best to monitor the specific side effects of medical treatments of Cushing's disease.
    Castinetti F
    Best Pract Res Clin Endocrinol Metab; 2022 Dec; 36(6):101718. PubMed ID: 36435719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical therapy of Cushing's disease: where are we now?
    Alexandraki KI; Grossman AB
    Front Horm Res; 2010; 38():165-173. PubMed ID: 20616508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cushing's disease: adrenal steroidogenesis inhibitors.
    Pivonello R; Simeoli C; Di Paola N; Colao A
    Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
    Lau D; Rutledge C; Aghi MK
    Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of Cushing's disease: what is the future?
    Fleseriu M; Petersenn S
    Pituitary; 2012 Sep; 15(3):330-41. PubMed ID: 22674211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Medical Treatment of Cushing's Disease: A Systematic Review and Meta-Analysis.
    Simões Corrêa Galendi J; Correa Neto ANS; Demetres M; Boguszewski CL; Nogueira VDSN
    Front Endocrinol (Lausanne); 2021; 12():732240. PubMed ID: 34603209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Treatment of Cushing's Disease.
    Pivonello R; De Leo M; Cozzolino A; Colao A
    Endocr Rev; 2015 Aug; 36(4):385-486. PubMed ID: 26067718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials.
    Pivonello R; Ferrigno R; De Martino MC; Simeoli C; Di Paola N; Pivonello C; Barba L; Negri M; De Angelis C; Colao A
    Front Endocrinol (Lausanne); 2020; 11():648. PubMed ID: 33363514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy.
    Fleseriu M; Petersenn S
    J Neurooncol; 2013 Aug; 114(1):1-11. PubMed ID: 23673515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the role of medical therapy in adrenal-dependent Cushing's syndrome?
    Braun LT; Reincke M
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101376. PubMed ID: 32063487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to the Patient Treated with Steroidogenesis Inhibitors.
    Castinetti F; Nieman LK; Reincke M; Newell-Price J
    J Clin Endocrinol Metab; 2021 Jun; 106(7):2114-2123. PubMed ID: 33675650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cushing's disease.
    Tritos NA; Biller BM
    Handb Clin Neurol; 2014; 124():221-34. PubMed ID: 25248590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of pharmacological options for Cushing's disease: what are the state-of-the-art options?
    Martino M; Aboud N; Lucchetti B; Salvio G; Arnaldi G
    Expert Opin Pharmacother; 2023 Apr; 24(5):557-576. PubMed ID: 36927238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
    Feelders RA; Hofland LJ; de Herder WW
    Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osilodrostat (Isturisa) for Cushing's disease.
    Med Lett Drugs Ther; 2021 Feb; 63(1617):21-23. PubMed ID: 33647005
    [No Abstract]   [Full Text] [Related]  

  • 17. New prospects for drug treatment in Cushing disease.
    Barahona Constanzo MJ; del Pozo Picó C
    Endocrinol Nutr; 2012 Dec; 59(10):599-605. PubMed ID: 23036936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mifepristone: is there a place in the treatment of Cushing's disease?
    Carmichael JD; Fleseriu M
    Endocrine; 2013 Aug; 44(1):20-32. PubMed ID: 23192246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget impact of pasireotide for the treatment of Cushing's disease, a rare endocrine disorder associated with considerable comorbidities.
    Truong HL; Nellesen D; Ludlam WH; Neary MP
    J Med Econ; 2014 Apr; 17(4):288-95. PubMed ID: 24617917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of Cushing's disease.
    Tritos NA; Biller BM
    J Neurooncol; 2014 May; 117(3):407-14. PubMed ID: 24146187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.